Analogi glutaminy jako inhibitory syntazy GLcN-6-P

• Autorzy: Melcer A.

Warianty tytułu

EN

Analogs of glutamine as inhibitors of synthase GLcN-6-P

• Języki publikacji: PL

Abstrakty

EN

Glucosamine-6-P (GlcN-6-P) synthase catalyzes the first committed step in chitin biosynthesis pathway, that is, transformation of D-fructose-6-phosphate (Fru-6-P) to D-glucosamine-6-phosphate [1]. Although the enzyme is also present in mammalian systems, substantial difference in physiological consequences of GlcN-6-P synthase inhibition in fungi and in mammals, constitute a firm molecular basis for the selective toxicity of specific enzyme inhibitors. The enzyme was proposed as a target for antifungal chemotherapy and a search for its selective inhibitors as potential antifungals has been continued. So far, two main groups of such compounds were identified: L-glutamine analogs and mimics of a putative cis-enolamine transition state intermediate but none of them demonstrated high antifungal activity, due to the inefficient uptake by the fungal cells. Among a number of known glutamine analogues some are selective inhibitors of GlcN-6-P synthase, not interacting with other enzymes utilising L-glutamine as substrate. One of them, N3-(4-methoxyfumaroyl)- l-2,3-diaminopropanoic acid (FMDP), gave rise to oligopeptidic compounds demonstrating remarkable antifungal activity [2]. Incorporation of FMDP into peptide structure allowed effective internalisation of the enzyme inhibitor by the way of peptide permeases, but on the other hand was a reason of substantial specific resistance, since peptides permeases are not essential for fungal cells [3, 4]. The second group of compounds comprises derivatives of phosphorylated aminosugars, including: 2-amino-2-deoxy-D-glucitol-6-phosphate (ADGP), arabinose-5- -phosphate oxime and 5-methylenephosphono-D-arabinohydroximolactone, as the most powerful GlcN-6-P synthase inhibitors [5–7]. These compounds exhibit very poor, if any, antifungal activity. This article provides a comprehensive overview of the present knowledge about inhibitors of glucosamine-6-phosphate and their synthesis.

Słowa kluczowe

PL

syntaza glukozamino--6-fosforanu; inhibitory syntazy GlcN-6-P; analogi glutaminy; centrum aktywne enzymu

EN

Glucosamine-6-P synthase; inhibitors of GlcN-6-P; antifungals; glutamine analogues; enzyme active center

• Wydawca: Polskie Towarzystwo Chemiczne
• Czasopismo: Wiadomości Chemiczne
• Rocznik: 2010
• Tom: [Z] 64, 11-12
• Strony: 995--1012
• Opis fizyczny: Bibliogr. 60 poz., schem., tab.

Twórcy

autor

Melcer A.

• Politechnika Gdańska, Wydział Chemiczny, Katedra Aparatury i Maszynoznawstwa Chemicznego, ul G. Narutowicza11/12, 80-233 Gdańsk Wrzeszcz,

Bibliografia

• [1] A. Herscovics, P. Orlean, FASEB J., 1993, 7, 540.
• [2] S. Mizerski, H. Chmara, R. Andruszkiewicz, E. Borowski, M. Zaremba, J. Borowski, Drugs Exptl.Clin. Res., 1988, 14, 461.
• [3] S. Milewski, R. Andruszkiewicz, E. Borowski, FEMS Microbiol. Lett., 1988, 50, 73.
• [4] J. Horak, Biochim. Biophys. Acta., 1997, 1331, 41.
• [5] M.-A. Badet-Denisot, C. Leriche, F. Masserie, B. Badet, Bioorg. Med. Chem. Lett., 1995, 5, 815.
• [6] C. Le Camus, M.-A. Badet-Denisot, B. Badet, Tetrahedron Lett., 1998, 39, 2571.
• [7] C. Le Camus. A. Chassange, M.-A. Badet-Denisot, B. Badet, Tetrahedron Lett., 1998, 39, 287.
• [8] F. Massiere, M.-A. Badet-Denisot, Cell. Mol. Life Sci., 1998, 54, 205.
• [9] A. Basak, A. Boudreault, A. Chen, M. Chretien, C. Lazure, J. Pept. Sci.,1995, 1, 385.
• [10] M. Badet-Denisot, L. René, B. Badet, Bull. Soc. Chim. Fr., 1993,130, 249-255.
• [11] B. Badet. P. Vermoote, P. Y. Haumont, F. Lederer, F. Le Goffic, Biochemistry, 1987, 26, 1940.
• [12] P.J. Winterburn, C. Phelps, Biochem. J., 1971, 121, 721.
• [13] M.-A. Denisot, F. Le Geoffic, B. Badet, Arch. Biochem. Biophys., 1991, 266, 225.
• [14] B. Badet, M.A. Badet-Denisot, B. Rene, Bull. Soc. Chim, Fr., 1993, 130, 155
• [15] C. Leriche, M.A. Badet-Denisot, B. Badet, J. Am. Chem. Soc., 1996, 118, 1797.
• [16] H. Zalkin, Meth. Enzymol., 1985, 113, 263.
• [17] R. Andruszkiewicz, H. Chmara, E. Borowski, J. Antibiot., 1984, 37, 1479.
• [18] S.L. Bearne, J. Biol. Chem., 1996, 271, 3052.
• [19] R. Andruszkiewicz, H. Chmara, S. Milewski, T. Zeniawa, E. Borowski, J. Med. Chem., 1990, 33, 2755.
• [20] R. Andruszkiewicz, H. Chmara, T. Zeniawa, E. Borowski, Eur. J. Med. Chem., 1994, 29,61.
• [21] S. Auvin, O. Cochet, N. Kucharczyk, F. Le Goffic, B. Badet, Bioorg. Chem., 1991, 19, 143.
• [22] H. Chmara, Biochim. Biophys. Acta 1984, 787, 45.
• [23] M.-A. Lacoste, L. Rene, B. Badet, Bull. Soc. Chim. Fr. 1993, 130, 249.
• [24] M. Wojciechowski, J. Mazerski, E. Borowski, J. Enzyme Inhib., 1995, 10, 17.
• [25] S. Milewski, D. Kuszczak, R. Jędrzejczak, R.J. Smith, A.J.P. Brown, G.W. Gooday, J. Biol. Chem., 1999, 274, 4000.
• [26] B. Walker, M.F. Brown, J.F. Lynas, S.L. Martin, A. McDowell, B. Badet, A.J. Hill, Bioorg. Med. Chem., 2000, 10, 2795.
• [27] S. Milewski, H. Chmara, E. Borowski, Drugs Expl. Clin. 1986, 12, 577.
• [28] F. Massiere, M.-A. Badet-Denisot, B. Badet, J. Am. Chem. Soc. 1997, 119, 5748.
• [29] S. Milewski, H. Chmara, E. Borowski, Arch. Microbiol., 1986, 145, 234.
• [30] H. Chmara, H. Zähner, Biochim. Biophys. Acta., 1984, 45, 787.
• [31] H. Chmara, H. Zähner, E. Borowski, J. Antibiot., 1984, 37, 1038.
• [32] H. Chmara, J. Gen. Microbiol., 1985, 131, 265.
• [33] E. Borowski, Acta Biochim. Polonic., 1957, 4, 231.
• [34] H. Chmara, M. Smulkowski, E. Borowski, Drugs Exptl. Clin. Res., 1980, 6, 7.
• [35] M.J. Crossley, A. Stamford, W. Aust., J. Chem. 1993, 46, 1443.
• [36] J.E. Baldwin, R.M. Adlington, M.B. Mitchell, Chem. Soc., Chem. Commun., 1993, 1332.
• [37] H. Chmara, R. Andruszkiewicz, E. Borowski, Biochim. Biophys. Acta, 1986, 870, 357.
• [38] H. Chmara, R. Andruszkiewicz, E. Borowski, Biochim. Biophys. Res. Commun., 1984, 120, 865.
• [39] R. Andruszkiewicz, H. Chmara, S. Milewski, E. Borowski, Int. J. Pept. Protein. Res. 1986, 27, 449.
• [40] R. Andruszkiewicz, H. Chmara, S. Milewski, L. Kasprzak, E. Borowski, Pol. J. Chem., 1993, 67, 673.
• [41] R. Andruszkiewicz, S. Milewski, E. Borowski, J. Enzyme Inhib., 1995, 9, 123.
• [42] N. Kucharczyk, M.A. Badet-Denisot, F. Le Goffic, B. Badet, Biochemistry, 1990, 29, 3668.
• [43] R. Andruszkiewicz, H. Chmara, T. Zeniawa, E. Borowski, Eur. J. Med. Chem., 1994, 29. 109.
• [44] M. Tarnowska, S. Ołdziej, A. Liwo, Z. Grzonka, E. Borowski, Eur. Biophys. J., 1992, 21, 273.
• [45] R. Cooper, A.C. Horan, F. Gentile, V. Gullo, D. Loebenberg, J. Marquez, M. Patel, M.S. Puar, I. Truumees, J. Antibiot., 1988, 41, 13.
• [46] R. Andruszkiewicz, T. Zieniawa, J. Antibiot., 1994, 47, 13.
• [47] S. Milewski, R. Andruszkiewicz, L. Kasprzak, J. Mazerski, F. Mignini, E. Borowski., Antimicrob. Agents Chemother., 1991, 35, 36.
• [48] R. Andruszkiewicz, H. Chmara, S. Milewski, E. Borowski, J. Med. Chem.,1987, 30, 1715.
• [49] R. Andruszkiewicz, S. Milewski, T. Zieniawa, E. Borowski, J. Med. Chem., 1990, 33, 132.
• [50] M.A. Denisot, F. Le Geoffic, B. Badet, Arch. Biochem. Biophys., 1991, 266, 225.
• [51] R.J. Smith, S. Milewski, A.J.P. Brown, G.W. Goodway, J. Bacteriol., 1996, 178, 2320.
• [52] M.-A. Badet-Denisot, C. Leriche, B. Badet, R.A.A. Muzzarelli, Chitin Enzymology., 1993, 161.
• [53] R. Andruszkiewicz, R. Jędrzejczak, T. Zieniawa, M. Wojciechowski, E. Borowski, J. Enzyme Inhib., 2000, 15, 420.
• [54] R. Andruszkiewicz, Zieniawa T., A. Walkowiak, J. Inhib. Med. Chem., 2005, 20, 115.
• [55] A. Walkowiak, R. Wakieæ, M.M. Bontemps-Gracz, R. Andruszkiewicz, J. Enzyme Inhib. Med. Chem., 2005 , 20, 439.
• [56] Milewski, H. Chmara, Biochim. Biophys. Acta., 1992, 225, 1115.
• [57] G. Shiorii, T. Yamadam, Chem. Pharm. Bulletin, 1974, 22, 859.
• [58] S. Friedrich-Bochnitscheh, H. Walkmana, H. Kunz, J. Org. Chem., 1989, 54, 751-758.
• [59] N. Ono, T. Hamada, T. Sato, Bull.Chem. Soc. Japan, 1978, 51, 2401.
• [60] D. Zgódka, R. Jędrzejczak, S. Milewski, E. Borowski, Bioorg. Med. Chem., 2001, 9, 931.